KWALITY PHARMACEUTICALS
Back to Cashflow Statement
|
KWALITY PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-17 Cr | ₹0.99 Cr | ₹5.66 Cr | ₹0.77 Cr | ₹12 Cr |
What is the latest Cash Flow from Financing Activities ratio of KWALITY PHARMACEUTICALS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-17 Cr |
Mar2023 | ₹0.99 Cr |
Mar2022 | ₹5.66 Cr |
Mar2021 | ₹0.77 Cr |
Mar2020 | ₹12 Cr |
How is Cash Flow from Financing Activities of KWALITY PHARMACEUTICALS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-17 Cr | Negative | |
Mar2023 | ₹0.99 Cr | -82.43 | |
Mar2022 | ₹5.66 Cr | 637.55 | |
Mar2021 | ₹0.77 Cr | -93.48 | |
Mar2020 | ₹12 Cr | - |
Compare Cash Flow from Financing Activities of peers of KWALITY PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KWALITY PHARMACEUTICALS | ₹724.5 Cr | -1% | -19.1% | 35.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,395.0 Cr | -4.1% | -9.8% | 8.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹151,422.0 Cr | -2.9% | -0.3% | 63.8% | Stock Analytics | |
CIPLA | ₹119,252.0 Cr | 0.1% | 4.4% | 2.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹101,889.0 Cr | -1.3% | -6.5% | 19% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,191.9 Cr | -4% | -5.9% | -7.8% | Stock Analytics |
KWALITY PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KWALITY PHARMACEUTICALS | -1% |
-19.1% |
35.9% |
SENSEX | -2% |
-2.3% |
2.5% |
You may also like the below Video Courses